8-Bromo-3-Methylxanthine CAS 93703-24-3 Linagliptin Chiyero Chapakatikati ≥99.0% Factory

Kufotokozera Kwachidule:

Dzina Lamankhwala: 8-Bromo-3-Methylxanthine

CAS: 93703-24-3

Chiyero: ≥99.0%

Maonekedwe: Ufa Woyera mpaka Kuwala Wachikasu

Yapakatikati ya Linagliptin (CAS: 668270-12-0) pamankhwala amtundu wa II shuga mellitus

Ubwino Wapamwamba, Kupanga Zamalonda

E-Mail: alvin@ruifuchem.com

Titumizireni imelo

Tsatanetsatane wa Zamalonda

Zogwirizana nazo

Zolemba Zamalonda

Kufotokozera:

Opanga Linagliptin ndi Zophatikiza Zofananira:
Linagliptin CAS 668270-12-0
Linagliptin Kholo Lapakatikati CAS 853029-57-9
8-Bromo-3-Methylxanthine CAS 93703-24-3
8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine CAS 666816-98-4
2-(Chloromethyl)-4-Methylquinazoline CAS 109113-72-6
(R)-3-(Boc-Amino)piperidine CAS 309956-78-3
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4
1-Bromo-2-Butyne CAS 3355-28-0

Chemical Properties:

Dzina la Chemical	8-Bromo-3-Methylxanthine
Mawu ofanana ndi mawu	8-Bromo-3-Methyl-3,7-dihydro-1H-purine-2,6-dione
Nambala ya CAS	93703-24-3
Nambala ya CAT	RF-PI501
Stock Status	Mu Stock, Kupanga Kukula Mpaka Matani
Molecular Formula	C6H5BrN4O2
Kulemera kwa Maselo	245.03
Melting Point	300 ℃ (lit.)
Kuchulukana	1.974g/cm3
Mtundu	Ruifu Chemical

Zofotokozera:

Kanthu	Zofotokozera
Maonekedwe	Ufa Woyera mpaka Kuwala Wachikasu
Chiyero	≥99.0%
Kutaya pa Kuyanika	≤0.50%
Zotsalira pa Ignition	≤0.50%
Chidetso Chimodzi	≤0.50%
Zonse Zonyansa	≤1.0%
Zitsulo Zolemera	≤20ppm
Test Standard	Enterprise Standard
Kugwiritsa ntchito	Wapakatikati wa Linagliptin (CAS: 668270-12-0)

Phukusi & Kusunga:

Phukusi: Botolo, Aluminiyamu zojambulazo thumba, 25kg/Cardboard Drum, kapena malinga ndi zofunika kasitomala.

Mkhalidwe Wosungira:Sungani m'mitsuko yosindikizidwa pamalo ozizira ndi owuma;Tetezani ku kuwala ndi chinyezi.

Ubwino:

FAQ:

Ntchito:

8-Bromo-3-Methylxanthine (CAS: 93703-24-3) ndi chochokera m'malo mwa Xanthine.Itha kugwiritsidwa ntchito popanga Linagliptin (CAS: 668270-12-0), yomwe ndi inhibitor yamphamvu komanso yosankha dipeptidyl peptidase-4 (DPP-4) yomwe ingagwiritsidwe ntchito pochiza matenda amtundu wa 2.Linavomerezedwa ndi a US FDA mu May 2011 kuti athe kuchiza matenda a shuga a Type 2 pamodzi ndi zakudya ndi masewera olimbitsa thupi.Woyambitsa ndi Boehringer Ingelheim (United States).